학술논문
Midostaurin plus daunorubicin or idarubicin for young and older adults with FLT3-mutated AML: a phase 3b trial
Document Type
Article
Author
Source
In: Blood Advances . (Blood Advances, 2023, 7(21):6441-6450)
Subject
Language
English
ISSN
24739537
24739529
24739529